HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

SPI-001

structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Phenanthrenes: 27
        SPI-001: 1
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Phenanthrenes: 27
    - SPI-001: 1

Experts

1.	Chuman, Yoshiro: 1 article (01/2012)
2.	Imagawa, Toshiaki: 1 article (01/2012)
3.	Kozakai, Yuuki: 1 article (01/2012)
4.	Sakaguchi, Kazuyasu: 1 article (01/2012)
5.	Takahashi, Yu: 1 article (01/2012)
6.	Tanino, Keiji: 1 article (01/2012)
7.	Yagi, Hiroaki: 1 article (01/2012)
8.	Yoshimura, Fumihiko: 1 article (01/2012)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2012 - "Our present study suggested that SPI-001 was a potential lead compound in developing anti-cancer drugs."
2.	Breast Neoplasms (Breast Cancer) 01/01/2012 - "SPI-001 inhibited PPM1D phosphatase activity in PPM1D-overexpressing human breast cancer cells and increased phosphorylation of p53. "

Related Drugs and Biologics

1.	Protein Phosphatase 2C